kübler rainer (19 resultados)

Hardcover. Condición: Gut. 89 S. : Ill., graph. Darst. ; 24 cm Guter Zustand. Sprache: Deutsch Gewicht in Gramm: 565.

Condición: New. In.

Condición: New. pp. xiv + 179.

Paperback. Condición: Brand New. reprint edition. 193 pages. 9.80x7.00x0.50 inches. In Stock.

Taschenbuch. Condición: Neu. Heart Failure and Arrhythmias | Johannes Brachmann (u. a.) | Taschenbuch | xiv | Englisch | 2012 | Springer | EAN 9783642753282 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Heart failure is a clinical entity characterized by a certain combination of symptoms and signs. Although there is neither a definition covering all aspects of it nor any generally accepted criteria for evaluating its severity, it is the endstage of many different heart diseases, in most cases associated with a poor prognosis. Approximately 50% of the patients with advanced heart failure die from pump failure, whereas the other half succumb suddenly and unexpectedly due to ventricular tachyar rhythmias. Although impaired left ventricular function is the main risk factor, sudden death may already occur in less severe cases of heart failure. In certain cardiac diseases, such as dilative cardiomyopathy, the occurrence of ventricular arrhythmias may be related directly to the underlying heart disease, as the frequency and severity (Lown classifica tion) of ventricular ectopics are not related to left ventricular impair ment. Treatment of ventricular tachyarrhythmias is still an unsolved prob lem, especially in patients with heart failure, who need it the most. The vast majority of antiarrhythmic agents are more or less negatively ino tropic and may therefore substantially aggravate ventricular impair ment. Nonpharmacological approaches - such as the implantation of a defibrillator - still require major surgery with the associated increased risk to the patient in heart failure. No agreement has yet been reached on the criteria for evaluating how effective treatment has been, either for heart failure or for ventricular tachyarrhythmias.

Paperback. Condición: Like New. Like New. book.

Broschiert. Condición: Befriedigend. Artikel stammt aus Nichtraucherhaushalt! GD3169 Sprache: Deutsch Gewicht in Gramm: 500.

kart. Condición: Sehr gut. 80 S. ; 21 cm 1. Auflage, tadelloses Exemplar 31 Sprache: Deutsch Gewicht in Gramm: 550.

Condición: Good.

Condición: Sehr gut. Zustand: Sehr gut | Produktart: Bücher | Keine Beschreibung verfügbar.

Condición: Gut. Zustand: Gut | Produktart: Bücher | Keine Beschreibung verfügbar.

Hardcover. Condición: gut. Wärmespeicher. In deutscher Sprache. pages.

Condición: new. Questo è un articolo print on demand.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Heart failure is a clinical entity characterized by a certain combination of symptoms and signs. Although there is neither a definition covering all aspects of it nor any generally accepted criteria for evaluating its severity, it is the endstage of many different heart diseases, in most cases associated with a poor prognosis. Approximately 50% of the patients with advanced heart failure die from pump failure, whereas the other half succumb suddenly and unexpectedly due to ventricular tachyar rhythmias. Although impaired left ventricular function is the main risk factor, sudden death may already occur in less severe cases of heart failure. In certain cardiac diseases, such as dilative cardiomyopathy, the occurrence of ventricular arrhythmias may be related directly to the underlying heart disease, as the frequency and severity (Lown classifica tion) of ventricular ectopics are not related to left ventricular impair ment. Treatment of ventricular tachyarrhythmias is still an unsolved prob lem, especially in patients with heart failure, who need it the most. The vast majority of antiarrhythmic agents are more or less negatively ino tropic and may therefore substantially aggravate ventricular impair ment. Nonpharmacological approaches - such as the implantation of a defibrillator - still require major surgery with the associated increased risk to the patient in heart failure. No agreement has yet been reached on the criteria for evaluating how effective treatment has been, either for heart failure or for ventricular tachyarrhythmias. 200 pp. Englisch.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Heart failure is a clinical entity characterized by a certain combination of symptoms and signs. Although there is neither a definition covering all aspects of it nor any generally accepted criteria for evaluating its severity, it is the endstage of many di.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Heart failure is a clinical entity characterized by a certain combination of symptoms and signs. Although there is neither a definition covering all aspects of it nor any generally accepted criteria for evaluating its severity, it is the endstage of many different heart diseases, in most cases associated with a poor prognosis. Approximately 50% of the patients with advanced heart failure die from pump failure, whereas the other half succumb suddenly and unexpectedly due to ventricular tachyar rhythmias. Although impaired left ventricular function is the main risk factor, sudden death may already occur in less severe cases of heart failure. In certain cardiac diseases, such as dilative cardiomyopathy, the occurrence of ventricular arrhythmias may be related directly to the underlying heart disease, as the frequency and severity (Lown classifica tion) of ventricular ectopics are not related to left ventricular impair ment. Treatment of ventricular tachyarrhythmias is still an unsolved prob lem, especially in patients with heart failure, who need it the most. The vast majority of antiarrhythmic agents are more or less negatively ino tropic and may therefore substantially aggravate ventricular impair ment. Nonpharmacological approaches - such as the implantation of a defibrillator - still require major surgery with the associated increased risk to the patient in heart failure. No agreement has yet been reached on the criteria for evaluating how effective treatment has been, either for heart failure or for ventricular tachyarrhythmias.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 200 pp. Englisch.

Condición: New. Print on Demand pp. xiv + 179 41 Figures.

Condición: New. PRINT ON DEMAND pp. xiv + 179.